EGFR
Onco
Daily
Twitter
Facebook
Youtube
RSS Feed
Linkedin
Facebook
RSS
Twitter
Youtube
Linkedin
July, 2024
June 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
« May
EGFR
Apr 22, 2024, 13:13 |
Blog
Fantastic to have our Co-founders Yvonne Diaz and Jan Clark attend BTOG24 in Belfast this week - Oncogene Cancer Research
Oncogene Cancer Research shared a post on LinkedIn: “Fantastic to have our Co-founders Yvonne Diaz…
Apr 21, 2024, 21:21 |
Insight
Mainak Bardhan: Miami Cancer Institute Research Precision Oncology symposium 2nd Annual at The Ritz Carlton spearhead by one and only Manmeet Ahluwalia
Mainak Bardhan, Chief Scientific Officer, Chief of Medical Oncology and Deputy Director of Miami Cancer Institute,…
Apr 16, 2024, 20:18 |
Blog
Save the Date for the 4th Annual “Living with EGFR-Mutant Lung Cancer” forum! - Dana Farber's EGFR-Mutant Lung Cancer Center
Quoting Dana Farber's EGFR-Mutant Lung Cancer Center on X/Twitter: "Save the Date: Register today for…
Apr 10, 2024, 08:56 |
Career
Pasi Jänne was recently recognised with the ACS 2024 Medal of Honour Award - Dana-Farber Cancer Institute
Dana-Farber Cancer Institute shared a post on LinkedIn: “Pasi Jänne, senior vice president for Translational…
Mar 31, 2024, 08:44 |
Blog
UCLA Health Jonsson Comprehensive Cancer Center's presentation at the annual meeting of the American Association for Cancer Research (AACR)
Investigators from the UCLA Health Jonsson Comprehensive Cancer Center will discuss the latest breakthroughs and cutting-edge science…
Mar 26, 2024, 00:22 |
Opinion
Wafik S. El-Deiry: WIN Consortium in cancer personalized medicine MTB had well over 30 participants
Wafik S. El-Deiry shared on LinkedIn: "Today’s WIN Consortium in cancer personalized medicine MTB had well…
Mar 4, 2024, 17:34 |
Insight
Jill Feldman: The importance of focusing on the 3 P's when discussing treatment options after a patient experiences progression on targeted therapy
Jill Feldman, Co-Founder of EGFR Resisters, posted on LinkedIn: "It was an honor to collaborate…
Jan 16, 2024, 05:48 |
Drugs
Stephen V Liu: Many updates in the 1.2024 National Comprehensive Cancer Network (NCCN) NSCLC guidelines
Stephen V Liu, Director of Thoracic Oncology and Developmental Therapeutics at Lombardi Comprehensive Cancer Center,…
Jan 8, 2024, 14:37 |
Blog
A 32-year-old lung cancer survivor, mother of 2 and oncology nurse practitioner - EGFR Resisters
EGFR Resisters shared a post on X/Twitter: "Meet Caroline, A 32-year-old lung cancer survivor, mother…
Sep 28, 2023, 19:02 |
Blog
Joel Bervell: Messages like this are my reminder of how important it is to create content about healthcare disparities and how powerful spreading accurate information via social media can be.
1
2
3
4
All:
31
Posts:
21 - 30
Eliot Levitt: The Yvonne Awards demonstrate something that it doesn't hurt to be reminded of
New data from the NEST clinical trial was presented at ESMOGI24 - Agenus
Zainab Shinkafi-Bagudu's latest commentary on Cervical Cancer Elimination Forum
New Paper Alert! Amivantamab-Lazertinib Improves Outcomes in High-Risk EGFR-Mutant NSCLC Subgroups: MARIPOSA Study Results
Learn more about overcoming barriers to immunotherapy for microsatellite stable colorectal cancer
Facebook
RSS Feed
Twitter
Linkedin
Youtube